Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension A. Davenport, C. Cox, R. Thuraisingham Kidney.

Slides:

Advertisements

Similar presentations

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Advertisements

A.M. Thompson, T.G. Pickering Kidney International

Optimization of pre-ESRD care: The key to improved dialysis outcomes

V.M. Campese, N. Mitra, D. Sandee Kidney International

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Beta blockers in the management of chronic kidney disease

Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: New therapeutic world beyond blood pressure reduction

Viper venom for diabetic nephropathy

Thinking Beyond New Clinical Guidelines: Update in Hypertension

Confounding: What it is and how to deal with it

Francesco Locatelli, Lucia Del Vecchio, Simeone Andrulli, Sara Colzani

Membranous nephropathy: When and how to treat

Viper venom for diabetic nephropathy

Volume 75, Issue 11, Pages (June 2009)

Fluid overload and residual renal function in peritoneal dialysis: the proof of the pudding is in the eating Wim Van Biesen, Achim Jörres Kidney International

Audit-based education: a potentially effective program for improving guideline achievement in CKD patients Moniek C.M. de Goeij, Joris I. Rotmans Kidney.

Response to is the reduction in urea distribution volume over time in clinically stable dialysis patients real? S. Andrulli, S. Di Filippo, F. Locatelli

Volume 80, Issue 9, Pages (November 2011)

Volume 69, Pages S11-S15 (April 2006)

Volume 94, Issue 3, Pages (September 2018)

V.M. Campese, N. Mitra, D. Sandee Kidney International

Homocysteine and risk in end-stage renal disease: a matter of context

Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: A simple assessment of symptom burden S.N. Davison, G.S.

A new era in phosphate binder therapy: What are the options?

Steven J. Rosansky, Richard J. Glassock Kidney International

Volume 70, Issue 11, Pages (December 2006)

Volume 72, Issue 12, Pages (December 2007)

Volume 71, Issue 11, Pages (June 2007)

Volume 71, Issue 11, Pages (June 2007)

Jennifer E. Flythe, Stephen E. Kimmel, Steven M. Brunelli

Volume 73, Pages S5-S17 (April 2008)

Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments R. Mishler, J.J. Sands, N.J. Ofsthun,

Volume 54, Issue 2, Pages (August 1998)

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Blood pressure targets in hemodialysis patients

Volume 69, Issue 10, Pages (May 2006)

Fructose intake as a risk factor for kidney stone disease

Volume 69, Issue 12, Pages (June 2006)

Cardiac medications and their association with cardiovascular events in incident dialysis patients: Cause or effect? Areef Ishani, Charles A. Herzog,

Volume 84, Issue 4, Pages (October 2013)

Volume 76, Issue 6, Pages (September 2009)

The third World Kidney Day: Looking back and thinking forward

Effects of hemodialysis on cardiac function

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

The future of renoprotection: Frustration and promises

Alternate-day dialysis may be needed for hemodialysis patients

Volume 71, Issue 6, Pages (March 2007)

Volume 67, Pages S52-S54 (January 2005)

Volume 73, Pages S72-S75 (April 2008)

Volume 64, Issue 4, Pages (October 2003)

Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study1 Robert N. Foley, Charles A. Herzog, Allan J.

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Carmine Zoccali, Francesca Mallamaci Kidney International

Volume 73, Issue 5, Pages (March 2008)

Organ transplantation goes to the movies

Volume 70, Pages S84-S90 (November 2006)

Volume 80, Issue 10, Pages (November 2011)

Is it the low-protein diet or simply the salt restriction?

Volume 71, Issue 5, Pages (March 2007)

Volume 70, Issue 3, Pages (August 2006)

Volume 70, Issue 5, Pages (September 2006)

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Volume 69, Issue 8, Pages (April 2006)

Optimization of pre-ESRD care: The key to improved dialysis outcomes

P.A. McFarlane, A.M. Bayoumi, A. Pierratos, D.A. Redelmeier

Copyright Notice You are authorized to use these slides subject to the following terms, conditions and exceptions: They are to be used solely for personal,

Presentation transcript:

Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension A. Davenport, C. Cox, R. Thuraisingham Kidney International Volume 73, Issue 6, Pages 759-764 (March 2008) DOI: 10.1038/sj.ki.5002745 Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 1 Percentage of patients in each of the 11 hospital dialysis centers achieving pre- and post-dialysis UK Renal Association blood pressure targets of <140/90 and <130/80 mm Hg, respectively. Kidney International 2008 73, 759-764DOI: (10.1038/sj.ki.5002745) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 2 Relationship between the percentage of patients not prescribed antihypertensive medications in each of the 11 dialysis centers and percentage of patients in that center achieving the pre- and post-dialysis UK Renal Association blood pressure targets. Kidney International 2008 73, 759-764DOI: (10.1038/sj.ki.5002745) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 3 Percentage of all hemodialysis patients audited achieving the pre-, post-dialysis, and both UK Renal Association blood pressure targets, whether they were prescribed antihypertensive medications or not. Kidney International 2008 73, 759-764DOI: (10.1038/sj.ki.5002745) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 4 Relationship between the percentage of patients achieving the UK Renal Association post-dialysis blood pressure target in each of the 11 dialysis centers and the percentage of dialysis patients with clinically symptomatic intradialytic hypotension requiring intravenous fluid resuscitation in that center. Kidney International 2008 73, 759-764DOI: (10.1038/sj.ki.5002745) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 5 The effect of different drug classes on clinically symptomatic intradialytic hypotension. Percentage of patients developing intradialytic hypotension prescribed α-blockers, calcium channel antagonists (Ca channel), β-blockers, and angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers (ACEI/ARBs) as monotherapy, and also those who were prescribed no antihypertensive medications (none). Kidney International 2008 73, 759-764DOI: (10.1038/sj.ki.5002745) Copyright © 2008 International Society of Nephrology Terms and Conditions